Trial · NCT04467697
Results by group858
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 858
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in 24-hour Average Ambulatory Systolic Blood Pressure After 120 Days Treatment | SOV2012-F1-treated | Baseline | 128.9 | 95% Confidence Interval 126.8 to 131.0 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Systolic Blood Pressure After 120 Days Treatment | SOV2012-F1-treated | Observed Visit 14E - Day 120E | 130.6 | 95% Confidence Interval 128.5 to 132.7 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Systolic Blood Pressure After 120 Days Treatment | SOV2012-F1-treated | Change from baseline (Visit 14E - Day 120E) | 1.7 | 95% Confidence Interval 0.3 to 3.1 | mmHg |
| Plasma and Serum Testosterone Efficacy of Oral SOV2012-F1 With up and Down Titration | NaF/EDTA PLASMA | Worst case scenario | 87.8 | 95% Confidence Interval 82.3 to 93.2 | percentage of participants |
| Plasma and Serum Testosterone Efficacy of Oral SOV2012-F1 With up and Down Titration | SERUM | Worst case scenario | 86.5 | 95% Confidence Interval 79.4 to 93.6 | percentage of participants |
| Plasma and Serum Testosterone Efficacy of Oral SOV2012-F1 With up and Down Titration | NaF/EDTA PLASMA | Day 90 completers | 96.1 | 95% Confidence Interval 92.7 to 99.4 | percentage of participants |
| Plasma and Serum Testosterone Efficacy of Oral SOV2012-F1 With up and Down Titration | SERUM | Day 90 completers | 87.5 | 95% Confidence Interval 80.6 to 94.4 | percentage of participants |
| Change From Baseline in 24-hour Average Ambulatory Systolic Blood Pressure After 180 Days Treatment. | SOV2012-F1-treated | Baseline | 128.9 | 95% Confidence Interval 126.8 to 131.0 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Systolic Blood Pressure After 180 Days Treatment. | SOV2012-F1-treated | Observed Visit 14E (Day 120E) | 130.6 | 95% Confidence Interval 128.5 to 132.7 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Systolic Blood Pressure After 180 Days Treatment. | SOV2012-F1-treated | Change from baseline (Day 120E - Day 1E) | 1.7 | 95% Confidence Interval 0.3 to 3.1 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Systolic Blood Pressure After 180 Days Treatment. | SOV2012-F1-treated | Observed Visit 16E (Day 180E) | 130.7 | 95% Confidence Interval 128.6 to 132.8 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Systolic Blood Pressure After 180 Days Treatment. | SOV2012-F1-treated | Change from baseline (Day 180E - Day 1E) | 1.8 | 95% Confidence Interval 0.3 to 3.2 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Diastolic Blood Pressure (dBP) After 120 Days and 180 Days of SOV2012-F1 Treatment. | SOV2012-F1-treated | Baseline | 76.2 | 95% Confidence Interval 74.6 to 77.9 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Diastolic Blood Pressure (dBP) After 120 Days and 180 Days of SOV2012-F1 Treatment. | SOV2012-F1-treated | Observed Visit 14E (Day 120E) | 76.9 | 95% Confidence Interval 75.3 to 78.5 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Diastolic Blood Pressure (dBP) After 120 Days and 180 Days of SOV2012-F1 Treatment. | SOV2012-F1-treated | Change from Baseline to Visit 14E (Day 120E) | 0.6 | 95% Confidence Interval -0.3 to 1.6 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Diastolic Blood Pressure (dBP) After 120 Days and 180 Days of SOV2012-F1 Treatment. | SOV2012-F1-treated | Observed Visit 16E (Day 180E) | 76.9 | 95% Confidence Interval 75.2 to 78.5 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Diastolic Blood Pressure (dBP) After 120 Days and 180 Days of SOV2012-F1 Treatment. | SOV2012-F1-treated | Change from Baseline to Visit 16E (Day 180E) | 0.6 | 95% Confidence Interval -0.4 to 1.6 | mmHg |
| Change From Baseline in 24-hour Average Ambulatory Heart Rate After 120 Days and 180 Days of Treatment. | SOV2012-F1-treated | Baseline | 76.3 | 95% Confidence Interval 74.4 to 78.3 | bpm |
| Change From Baseline in 24-hour Average Ambulatory Heart Rate After 120 Days and 180 Days of Treatment. | SOV2012-F1-treated | Observed Visit 14E (Day 120E) | 77.0 | 95% Confidence Interval 75.1 to 79.0 | bpm |
| Change From Baseline in 24-hour Average Ambulatory Heart Rate After 120 Days and 180 Days of Treatment. | SOV2012-F1-treated | Change from baseline to Visit 14E (Day 120E) | 0.7 | 95% Confidence Interval -0.5 to 1.9 | bpm |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04467697/results